Corient Capital Partners, LLC Moderna, Inc. Transaction History
Corient Capital Partners, LLC
- $1.34 Billion
- Q3 2022
A detailed history of Corient Capital Partners, LLC transactions in Moderna, Inc. stock. As of the latest transaction made, Corient Capital Partners, LLC holds 5,500 shares of MRNA stock, worth $216,810. This represents 0.06% of its overall portfolio holdings.
Number of Shares
5,500
Previous 5,382
2.19%
Holding current value
$216,810
Previous $769,000
2.21%
% of portfolio
0.06%
Previous 0.06%
Shares
8 transactions
Others Institutions Holding MRNA
# of Institutions
913Shares Held
236MCall Options Held
10.6MPut Options Held
18.7M-
Vanguard Group Inc Valley Forge, PA40.2MShares$1.59 Billion0.05% of portfolio
-
Baillie Gifford & CO38.9MShares$1.53 Billion1.28% of portfolio
-
Black Rock Inc. New York, NY25.6MShares$1.01 Billion0.07% of portfolio
-
State Street Corp Boston, MA16.8MShares$664 Million0.05% of portfolio
-
Theleme Partners LLP London, X07.23MShares$285 Million28.47% of portfolio
About Moderna, Inc.
- Ticker MRNA
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 391,200,000
- Market Cap $15.4B
- Description
- Moderna, Inc., a biotechnology company, discovers, develops, and commercializes messenger RNA therapeutics and vaccines for the treatment of infectious diseases, immuno-oncology, rare diseases, cardiovascular diseases, and auto-immune diseases in the United States, Europe, and internationally. Its respiratory vaccines include COVID-19, flu, resp...